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Abstract
OBJECTIVE: To observe the effects of Bushenwe-
nyanghuayu decoction (BD), a Traditional Chinese
Medicine (TCM), on the serum concentration of
nerve growth factor (NGF) and bradykinin (BK), and
protein and mRNA levels of NGF and bradykinin B1
receptor (BKB1R) in a mouse model of endometrio-
sis dysmenorrhea.
METHODS: Seventy-five experimental female
BALB/c mice were randomly divided into five
groups, 15 mice each: sham, model, BD high dose
(61.67 g/kg), BD low dose (15.42 g/kg), and gestri-
none (0.4 mg/kg) groups. All the mice except for
those in the sham group underwent auto-trans-
plantation surgery and were gavaged estradiol val-
erate (0.5 mg/kg, daily for 12 days) after surgery. On
the 12th day, 1 h after administration, writhing re-
sponse was induced by intraperitoneal injection of
oxytocin at 2 U/mouse. The writhing frequency and
latency were recorded and the volume of the ecto-
pic foci was measured. The concentration of serum
NGF and BK was detected by enzyme-linked immu-
nosorbent assay, the protein expression of NGF and
BKB1R was tested by immunohistochemistry and
western blotting, and NGF and BKB1R mRNAs were
detected by real-time PCR.
RESULTS: Compared with the model group, the vol-
ume of the ectopic foci in the treatment groups
was significantly lower (P < 0.01), the writhing fre-
quency was decreased (P < 0.05), and the writhing
latency was prolonged (P < 0.01). Compared with
the sham group, serum NGF and BK levels in the
model group were significantly increased (P <
0.01). There were positive correlations for writhing
frequency among the NGF and BK groups (P <
0.01). The serum NGF and BK levels were significant-
ly lower in the treatment groups than the model
group (P < 0.05). The protein expression of NGF,
BKB1R was significantly decreased in the treatment
groups compared with the model group (P < 0.01).
NGF and BKB1R mRNA expression was significantly
decreased in the treatment groups compared with
the model group (P < 0.01).
CONCLUSION: NGF and BK/BKB1R may play an im-
portant role in the development of endometrio-
sis-associated dysmenorrhea, and BD was found to
inhibit the development of endometriosis and re-
lieve dysmenorrhea by influencing NGF and BK/
BKB1R mRNA and protein levels.
© 2015 JTCM. All rights reserved.
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INTRODUCTION
Endometriosis is a gynecological disease affecting
10%-14% of reproductive-aged women, with symp-
toms such as dysmenorrhea, dyspareunia, and infertili-
ty,1 of which dysmenorrhea is the most common and
most specific symptom. However, the mechanisms by
which endometriotic lesions produce pain and hyperal-
gesia are poorly understood. Numerous theories have
been proposed to explain the cause of pain in endome-
triotic tissue, including production and release of pros-
taglandins;2 inflammatory mediators such as kinins, his-
tamine, interleukins, etc.;3 and abnormal distribution
of nerve fibers.4 Recently, nerve growth factor (NGF)
has been proposed as one of the key factors responsible
not only for the promotion of nerve fiber growth but
also for the onset and maintenance of pain in a variety
of diseases.5 Additionally, since NGF is a pain media-
tor, it can promote mast cells to release bradykinin
(BK) and other inflammatory mediators.6 The combi-
nation of bradykinin and its B1 receptor (bradykinin B1
receptor, BKB1R) are able to activate pain. Whether
NGF, BK, and BKB1R help in improving endometrio-
sis-associated dysmenorrhea remains to be seen. In our
previous study,7,8 we found that Bushenwenyanghuayu
decoction (BD) had a significant clinical effect, espe-
cially in alleviating pain related to endometriosis.
Based on previous studies,9,10 a BALB/c mouse endome-
triosis model was established. In the present study
writhing response was examined and the effect of BD
on NGF and BK/BKB1R levels was investigated.
MATERIALS ANDMETHODS
Animals
A total of 75 female BALB/c mice, weighing 18-22 g
and aged 6-8 weeks (License No. 1211067), were ac-
quired from the Hebei Experimental Animal Center.
Mice were maintained at constant temperature
(20-23 ℃ ) and humidity (45%-60% ) under a 12-h
light/dark cycle, and all mice had free access to food
and water. All animal studies were approved by the In-
stitutional Animal Care and Use Committee of the He-
bei University of ChineseMedicine. Themice were anes-
thetized with an injection of 5% chloral hydrate (6 mL/
kg, supported by Shanghai Jin Sui biological technolo-
gy Co., Ltd.,) into the abdominal cavity before opera-
tion and sacrifice to relieve the animal's suffering.
Bushenwenyanghuayu decoction
BD consists of Fuzi (Radix Aconiti Lateralis Preparata)
6 g, Rougui (Cortex Cinnamomi Cassiae) 10 g, Xiao-
huixiang (Fructus Foeniculi) 10 g, Yanhusuo (Rhizoma
Corydalis Yanhusuo) 15 g, Chuanxiong (Rhizoma Ch-
uanxiong) 10 g, Chuanniuxi (Radix Cyathulae) 10 g,
Chuanlianzi (Fructus Toosendan) 15 g, Dangshen (Ra-
dix Codonopsis) 15 g, Baizhu (Rhizoma Atractylodis Mac-
rocephalae) 15 g, Moyao (Myrrh) 10 g, Jiuxiangchong
(Aspongopus) 9 g, Gouji (Rhizoma Cibotii) 30 g,
Sangjisheng (Herba Taxilli Chinensis) 30 g. These
crude herbs were purchased from the Shijiazhuang Le-
rentang Drugstore. Following Traditional Chinese
Medicine (TCM), the BD was made at a high dose
(6.17 g/mL) and a low dose (1.54 g/mL) prepared by
the Chinese Medicine Pharmacological Laboratory of
Hebei University of Traditional Chinese Medicine.
Gestrinone capsules made by Zizhu Pharmaceutical
Limited Company (Beijing, China), were powdered
and dissolved in deionized water at a concentration of
0.04 mg/mL. Estradiol valerate tablets made by DEL-
PHARM Lille S.A.S. (Lys-Lez-Lannoy, France), were
powdered and dissolved in deionized water at a concen-
tration of 0.05 mg/mL. Gentamycin sulfate injection
was purchased from Zhuofeng Pharmaceutical Limited
Company (Zhengzhou, China).
Reagents
BK enzyme-linked immunosorbent assay (ELISA) kit
was purchased from Enzo Life Sciences, Inc, (Farming-
dale, NY, USA). NGF ELISA kit was purchased from
Shanghai Senxiong Science and Technology Industrial
Limited Company (Shanghai, China). Rabbit poly-
clonal antibody to BKB1R was purchased from Santa
Cruz Biotechnology (Dallas, TX, USA). Rabbit mono-
clonal to NGF antibody was purchased from Epito-
mics (Burlingame, CA, USA). Rabbit polyclonal toβ-actin antibody was purchased from Hangzhou
Huaan Biology Technology Limited (Hangzhou, Chi-
na). Reverse Transcription kit M-MLV and Fluorescent
PCR Core Reagent Kits SYBR Green I were purchased
from MBI (Vilnius, Lithuania). Trizol Reagent was pur-
chased from Invitrogen (Carlsbad, CA, USA).
Grouping and treatment
Seventy-five mice total were randomly divided into five
groups, 15 mice each, by the random number table
method: sham group, model group, BD high dose
group, BD low dose group, and gestrinone group. Be-
fore establishing the model, estradiol valerate at
0.5 mg/kg was administrated to all mice by gavage for
2 days to be in the estrus period. Except for the sham
group, other mice underwent auto-transplantation sur-
gery to establish endometriosis dysmenorrhea as de-
scribed in the literature.11,12 Mice were anesthetized by
intraperitoneal injection with 5% chloral hydrate
(6 mL/kg). Using aseptic technique, an abdominal inci-
sion was made to expose the uterus and a 1-1.5 cm seg-
ment of the left uterine horn was removed and placed
in warm saline. The uterus was cut open longitudinally
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INTRODUCTION
Endometriosis is a gynecological disease affecting
10%-14% of reproductive-aged women, with symp-
toms such as dysmenorrhea, dyspareunia, and infertili-
ty,1 of which dysmenorrhea is the most common and
most specific symptom. However, the mechanisms by
which endometriotic lesions produce pain and hyperal-
gesia are poorly understood. Numerous theories have
been proposed to explain the cause of pain in endome-
triotic tissue, including production and release of pros-
taglandins;2 inflammatory mediators such as kinins, his-
tamine, interleukins, etc.;3 and abnormal distribution
of nerve fibers.4 Recently, nerve growth factor (NGF)
has been proposed as one of the key factors responsible
not only for the promotion of nerve fiber growth but
also for the onset and maintenance of pain in a variety
of diseases.5 Additionally, since NGF is a pain media-
tor, it can promote mast cells to release bradykinin
(BK) and other inflammatory mediators.6 The combi-
nation of bradykinin and its B1 receptor (bradykinin B1
receptor, BKB1R) are able to activate pain. Whether
NGF, BK, and BKB1R help in improving endometrio-
sis-associated dysmenorrhea remains to be seen. In our
previous study,7,8 we found that Bushenwenyanghuayu
decoction (BD) had a significant clinical effect, espe-
cially in alleviating pain related to endometriosis.
Based on previous studies,9,10 a BALB/c mouse endome-
triosis model was established. In the present study
writhing response was examined and the effect of BD
on NGF and BK/BKB1R levels was investigated.
MATERIALS ANDMETHODS
Animals
A total of 75 female BALB/c mice, weighing 18-22 g
and aged 6-8 weeks (License No. 1211067), were ac-
quired from the Hebei Experimental Animal Center.
Mice were maintained at constant temperature
(20-23 ℃ ) and humidity (45%-60% ) under a 12-h
light/dark cycle, and all mice had free access to food
and water. All animal studies were approved by the In-
stitutional Animal Care and Use Committee of the He-
bei University of ChineseMedicine. Themice were anes-
thetized with an injection of 5% chloral hydrate (6 mL/
kg, supported by Shanghai Jin Sui biological technolo-
gy Co., Ltd.,) into the abdominal cavity before opera-
tion and sacrifice to relieve the animal's suffering.
Bushenwenyanghuayu decoction
BD consists of Fuzi (Radix Aconiti Lateralis Preparata)
6 g, Rougui (Cortex Cinnamomi Cassiae) 10 g, Xiao-
huixiang (Fructus Foeniculi) 10 g, Yanhusuo (Rhizoma
Corydalis Yanhusuo) 15 g, Chuanxiong (Rhizoma Ch-
uanxiong) 10 g, Chuanniuxi (Radix Cyathulae) 10 g,
Chuanlianzi (Fructus Toosendan) 15 g, Dangshen (Ra-
dix Codonopsis) 15 g, Baizhu (Rhizoma Atractylodis Mac-
rocephalae) 15 g, Moyao (Myrrh) 10 g, Jiuxiangchong
(Aspongopus) 9 g, Gouji (Rhizoma Cibotii) 30 g,
Sangjisheng (Herba Taxilli Chinensis) 30 g. These
crude herbs were purchased from the Shijiazhuang Le-
rentang Drugstore. Following Traditional Chinese
Medicine (TCM), the BD was made at a high dose
(6.17 g/mL) and a low dose (1.54 g/mL) prepared by
the Chinese Medicine Pharmacological Laboratory of
Hebei University of Traditional Chinese Medicine.
Gestrinone capsules made by Zizhu Pharmaceutical
Limited Company (Beijing, China), were powdered
and dissolved in deionized water at a concentration of
0.04 mg/mL. Estradiol valerate tablets made by DEL-
PHARM Lille S.A.S. (Lys-Lez-Lannoy, France), were
powdered and dissolved in deionized water at a concen-
tration of 0.05 mg/mL. Gentamycin sulfate injection
was purchased from Zhuofeng Pharmaceutical Limited
Company (Zhengzhou, China).
Reagents
BK enzyme-linked immunosorbent assay (ELISA) kit
was purchased from Enzo Life Sciences, Inc, (Farming-
dale, NY, USA). NGF ELISA kit was purchased from
Shanghai Senxiong Science and Technology Industrial
Limited Company (Shanghai, China). Rabbit poly-
clonal antibody to BKB1R was purchased from Santa
Cruz Biotechnology (Dallas, TX, USA). Rabbit mono-
clonal to NGF antibody was purchased from Epito-
mics (Burlingame, CA, USA). Rabbit polyclonal toβ-actin antibody was purchased from Hangzhou
Huaan Biology Technology Limited (Hangzhou, Chi-
na). Reverse Transcription kit M-MLV and Fluorescent
PCR Core Reagent Kits SYBR Green I were purchased
from MBI (Vilnius, Lithuania). Trizol Reagent was pur-
chased from Invitrogen (Carlsbad, CA, USA).
Grouping and treatment
Seventy-five mice total were randomly divided into five
groups, 15 mice each, by the random number table
method: sham group, model group, BD high dose
group, BD low dose group, and gestrinone group. Be-
fore establishing the model, estradiol valerate at
0.5 mg/kg was administrated to all mice by gavage for
2 days to be in the estrus period. Except for the sham
group, other mice underwent auto-transplantation sur-
gery to establish endometriosis dysmenorrhea as de-
scribed in the literature.11,12 Mice were anesthetized by
intraperitoneal injection with 5% chloral hydrate
(6 mL/kg). Using aseptic technique, an abdominal inci-
sion was made to expose the uterus and a 1-1.5 cm seg-
ment of the left uterine horn was removed and placed
in warm saline. The uterus was cut open longitudinally
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and attached to the intimal surface to the right side of
the abdominal wall and sutured diagonally with 4-0 ab-
sorbable thread. Sham surgeries were performed on the
sham group using the same steps as the endometriosis
surgeries, but no tissue was sutured to the abdominal
wall. After confirming hemostasis, the incision was su-
tured closed in layers, and gentamycin sulfate injection
(8 mg/mouse) was intraperitoneally injected for 3 days
to prevent infection. From the first postoperative day,
each group was administrated agents according to the
following scheme: deionized water was administrated to
mice in the model group and 6 h later estradiol valerate
at 0.5 mg/kg; BD at 61.67 g/kg to mice in the high dose
group and 6 h later estradiol valerate at 0.5 mg/kg; BD
at 15.42 g/kg to mice in the low dose group and 6 h lat-
er estradiol valerate at 0.5 mg/kg; gestrinone at 0.4 mg/
kg to mice in the gestrinone group twice a week, and
other time water instead, 6 h later estradiol valerate at
0.5 mg/kg; deionized water was orally administered to
mice in the sham group. Mice in the five groups were
all administrated agents by gavage for 12 days at an in-
tragastric volume of 1 mL/100 g. At the 12th day after
1 h of administration of estradiol valerate, oxytocin at
2U/mouse was injected intraperitoneally to all mice ex-
cept for those in the sham group to induce writhing re-
sponse. Normal saline at 0.2 mL/mouse was injected to
mice in the sham group.
Specimen collection
Thirty minutes after observing the writhing response,
the mice were anesthetized by intraperitoneal injection
of 5% chloral hydrate (6 mL/kg) and decapitated. Then
the blood was collected and centrifuged at 1800 ×g for
15 min to separate the serum, and then the serum sam-
ples were stored at﹣80 ℃ for ELISA testing. The vol-
ume of ectopic foci (length × width × height, unit
mm3) was measured. Some of the samples including
the uterus and ectopic foci were fixed in 4% parafor-
maldehyde and embedded in paraffin. The residual
samples were immediately placed in liquid nitrogen,
and stored at﹣80℃ before use.
ELISA for measuring serum NGF and BK
Both NGF and BK were determined using ELISA as-
say according to the kit instructions.
Immunohistochemistry for detection of NGF and
BKB1R
Immunohistochemistry streptavidin-perosidase meth-
od was used for detection of NGF and BKB1R. Cells
positive for NGF and BKB1R appeared with pale
brown stained cytoplasm. The positively-stained cells
were counted in 10 random high-power fields of each
sample under light microscope. HMIAS-2000 patholo-
gy picture analysis system (Qianping Audiovisual Com-
pany, Wuhan, China) was used to view the tissues and
staining was measured by optical density (OD) of the
positive signal.
Western blotting for NGF and BKB1R
Whole protein lysates were processed as described pre-
viously.13 After protein content was determined by the
Bradford method, proteins were separated by
SDS-polyacrylamide gel electrophoresis and then trans-
ferred onto a PVDF membrane. The membrane was
blocked with 5% skim milk in tris buffer saline. The
membrane was then incubated at 4 ℃ overnight with
primary antibodies. After washing, the membranes
were incubated with a secondary conjugated antibody
(anti-rabbit IgG antibody 1∶10000) for 1 h at room
temperature. The protein bands were scanned, and ana-
lyzed on an Odyssey scanner (LI-COR, Lincoln, NE,
USA). Data are presented as a ratio of NGF or BKB1R
and β-actin, respectively.
Real-time PCR for measuring NGF and BKB1R
mRNA
Total RNA was extracted from the tissue specimens us-
ing Trizol Reagent and reverse transcription of RNA to
cDNA was performed using a reverse transcriptase kit
according to the manufacturer's protocol. The synthet-
ic oligonucleotide primer sequences for NGF, BKB1R,
and GAPDH were as follows: NGF 5′-TCAT-
CATCCCATCCCATCT-3′ and 5′-TTCACCTCTC
CCAACACCA-3′ , BKB1R 5′-GCTGCCAACATT-
TATCATCTCC-3′ and 5′-GCCCAAGACAAACAC-
CAGA-3′ , GAPDH 5′-TGAACGGGAAGCTCACT-
GG-3′ and 5′-GCTTCACCACCTTCTTGAT-
GTC-3′ . Real-time PCR was performed using SYBR
green I according to the manufacturer's instructions.
PCR was performed at 42 ℃ for 50 min, 95 ℃ for 5
min, followed by 40 cycles at 94 ℃ for 30 s, 58 ℃ for
30 s, and 72 ℃ for 30 s. A comparative cycle of thresh-
old fluorescence (Ct) method was used and the relative
transcript amount of the target gene was normalized to
that of GAPDH using the 2−ΔΔCt method based on a pre-
vious study.14 The final results of the real-time PCR
were expressed as the ratio of mRNA of control.
Statistical analysis
Data are presented as mean ± standard deviation
( xˉ ± s ). Statistical analyses were performed using
SPSS 13.0 (SPSS Inc., Chicago, IL, USA). Statistical
comparisons were based on analysis of one-way analy-
sis of variance followed by post-hoc least significant dif-
ferece and Student-Newman-Keuls test. Correlation be-
tween two variables was evaluated by linear correlation
analysis with Pearson correlation coefficient, and differ-
ences were considered statistically significant at P <
0.05.
RESULTS
Comparison of writhing response among groups
Except for the sham group, the mice in the other
groups all displayed the writhing response. Compared
with the model group, the writhing latency was pro-
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longed and the writhing frequency was reduced in the
BD high dose and low dose groups and the gestrinone
group. The differences were statistically significant (P <
0.01 or P < 0.05), but there were no significant differenc-
es among treatment groups (P > 0.05) (Table 1).
Comparison of ectopic foci volume among groups
Except for the sham group, the ectopic foci were well
developed in the other groups. Compared with the
model group, the volume of the ectopic foci in the BD
high-dose and low-dose groups and the gestrinone
group became significantly smaller (P < 0.01), but
there were no significant differences among treatment
groups (P > 0.05) (Table 2).
Comparison of serum NGF and BK
The level of NGF and BK in the model group was sig-
nificantly higher than that of the sham group (P <
0.01), whereas those in the treatment groups were sig-
nificantly lower than that of the model group (P <
0.05, P < 0.01), and there were no significant differenc-
es among the treatment groups (P > 0.05) (Table 3).
Correlation analysis for NGF, BK, and writhing
response
The results suggested that there were positive correla-
tions between NGF and BK, and they both were posi-
tively correlated with writhing frequency (P < 0.01),
but there was no correlation with writhing latency (P >
0.05) (Table 4).
Comparison of NGF and BKB1R protein expression
by immunohistochemistry
The NGF and BKB1R proteins were mainly expressed
in the cytoplasm of cells in the endometrial stroma or
presented as brown granule staining in glands. The ex-
pressions of NGF and BKB1R in the uteri of the mod-
el-group mice were significantly higher than that in the
sham mice (P < 0.01), and those in treatment groups
were significantly lower than that of the model group
not only in the uterus but also in the ectopic foci (P <
0.01), but there was no significant difference among
the treatment groups (P > 0.05) (Figures 1, 2).
Comparison of NGF and BKB1R protein expression
by Western blot
Western blot analysis showed that NGF and BKB1R
protein expression in the model group increased signifi-
cantly compared with the sham group (P < 0.01), and
protein expression in the treatment groups decreased
significantly compared with that of the model group
(P < 0.01). There was no significant difference among
treatment groups (P > 0.05) (Figure 3)
Comparison of mRNA for NGF and BKB1R by
real-time PCR
mRNA for NGF in the uterus increased significantly
in the model group compared with the sham group
(P < 0.01), and decreased significantly in the treatment
groups compared with the model group (all P < 0.01),
and there were significant differences between BD high
dose and gestrinone groups (P < 0.01). The ectopic fo-
ci level of NGF mRNA in the treatment groups de-
creased significantly compared with the model group
(all P < 0.01), and the differences between BD
high-dose group and gestrinone, and the BD low-dose
group and gestrinone were statistically significant (P <
0.01, P < 0.05).
BKB1R mRNA in the uterus increased significantly in
the model group compared with the sham group (P <
Group
Sham
Model
BD high
BD low
Gestrinone
n
15
15
13
15
14
Writhing latency
(s)
-
32±10
88±25a
91±32a
89±24a
Writhing frequency
(times)
-
22±10
13±5b
10±5a
7±5a
Notes: the sham group was administered deionized water; the
model group was treated with estradiol valerate combined with
oxytocin. The BD high dose group, BD low dose group, and
gestrinone group were intragastrically administered the BD high
dose decoction at 61.67 g/kg, BD low dose decoction at 15.42 g/
kg, and gestrinone solution at 0.4 mg/kg, respectively for 12 days.
BD: Bushenwenyang decoction. Comparison with the model
group, aP < 0.01, bP < 0.05.
Table 1 Comparison of writhing response ( xˉ ± s)
Table 2 Comparison of ectopic foci volume ( xˉ ± s)
Group
Sham
Model
BD high
BD low
Gestrinone
n
15
15
13
15
14
Volume (mm3)
-
43±11
23±9a
20±8a
28±10a
Notes: the sham group was administered deionized water, the
model group was treated with estradiol valerate combined with
oxytocin. The BD high dose group, BD low dose group, and
gestrinone group were intragastrically administered the BD high
dose decoction at 61.67 g/kg, BD low dose decoction at 15.42 g/
kg, and gestrinone solution at 0.4 mg/kg, respectively for 12 days.
BD: Bushenwenyang decoction. Comparison with the model
group, aP < 0.01.
Group
Sham
Model
BD high
BD low
Gestrinone
n
15
15
13
15
14
bradykinin (ng/mL)
3.4±1.0a
7.3±0.7b
4.4±1.1a
4.5±1.9a
4.6±1.4a
NGF (pg/mL)
38.8±11.2a
73.4±14.2b
48.4±17.8c
52.6±16.5c
49.7±17.9c
Table 3 Serum level of NGF and BK ( xˉ ± s)
Notes: the sham group was administered deionized water. The
model group was treated with estradiol valerate combined with
oxytocin. The BD high dose group, BD low dose group, and
gestrinone group were intragastrically administered the BD high
dose decoction at 61.67 g/kg, BD low dose decoction at 15.42 g/
kg, and gestrinone solution at 0.4 mg/kg, respectively for 12 days.
BD: Bushenwenyang decoction; BK: bradykinin; NGF: nerve
growth factor. Comparison with the model group, aP < 0.01,
cP < 0.05; comparison with the sham group, bP < 0.01.
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0.01), and decreased significantly in the treatment
groups compared with the model group (all P < 0.01).
The differences between the BD high-dose group and
gestrinone, and the BD low-dose group and gestrinone
were statistically significant (P < 0.01, P < 0.05). The
level of BKB1R mRNA in ectopic foci in the treatment
groups decreased significantly compared with the mod-
el group (all P < 0.01), and the difference between the
BD high-dose and gestrinone groups was statistically
significant (P < 0.01) (Table 5).
DISCUSSION
In gynecological concepts of TCM, the nature of endo-
metriosis is blood stasis, and the existence of blood sta-
sis blocks Chong Ren and Bao channels, followed by
dysmenorrhea, which slowly leads to kidney deficiency.
Therefore, we consider the basic pathogenesis of the
disease as kidney deficiency and blood stasis,15,16 and
BD as a therapy for it. In this study, we investigated
the association among endometriosis-associated dys-
menorrhea, NGF, and BK/BKB1R. We measured the
concentration of NGF and BK in mouse serum, and
found that there were positive correlations between the
concentrations of NGF and BK and writhing frequen-
cy, indicating that NGF and BK participate in the gen-
eration or persistence of pain due to endometriosis.
The higher the content of NGF and BK, the greater
was the degree of dysmenorrhea. The present study ver-
ified that the expression of NGF and BKB1R in the
model group was stronger than the sham group both at
the protein level or the mRNA level. On the one hand,
NGF can increase the number of sensory neurons and
is selectively trophic for small fiber sensory neurons
and sympathetic ganglion neurons that participate in
mediating pain sensation.5On the other hand, as a type
of pain substance, NGF directly participates in the gen-
eration of pain sensation, and there is a combined ef-
fect of NGF and BK in the occurrence of endometrio-
sis-associated dysmenorrhea. The combination of BK
and its over-expressed receptor BKB1R can cause the
release of Ca2+, activation of phosphoric acid protein ki-
nase C, phosphorylation of transient receptor potential
vanilloid receptor complexes, and can strengthen the
entry of ions and reduce the activation threshold of al-
gesiroreceptor, causing different types of pain.17 This
process promotes the release of prostaglandins and di-
rectly causes pain and hyperpathia.18 Thus, NGF and
BK/BKB1R may play pivotal roles in the occurrence
and development of dysmenorrhea with endometriosis.
The results showed significant alterations in serum
NGF and BK after BD treatment. The expression of
NGF and BKB1R proteins decreased, and NGF and
BKB1R mRNA levels were decreased. On the one
hand, BD can inhibit nerve fiber regeneration by re-
ducing NGF level, so as to block the transmission of
pain signals. On the other hand, it is able to slow
down the release of pain substances by decreasing BK
concentration, and thus alleviating dysmenorrhea. In-
hibiting the expression of NGF and BK/BKB1R has
the possible effect of reducing the incidence of inflam-
matory pain by blocking the inflammatory response.
Factor 1
Nerve growth factor
Nerve growth factor
Bradykinin
Bradykinin
Nerve growth factor
Factor 2
Writhing frequency
Writhing latency
Writhing frequency
Writhing latency
BK
r value
0.574
﹣0.335
0.712
﹣0.307
0.569
Sig
0.008
0.149
0.000
0.188
0.009
Table 4 Correlation of nerve growth factor and bradykinin with writhing response
Notes: r: correlation coefficient values; Sig: significance; BK: bradykinin.
Group
Sham
Model
BD high
BD low
Gestrinone
n
15
15
13
15
14
Nerve growth factor mRNA
Uterus
1.01±0.12a
3.27±0.52b
1.24±0.14ac
2.17±0.33ab
2.24±0.20ab
Ectopic foci
-
3.85±0.20
1.32±0.32ac
1.70±0.45ad
2.50±0.47a
Bradykinin B1 receptor mRNA
Uterus
0.90±0.09ac
2.84±0.63bc
1.31±0.20ac
1.38±0.29ad
2.06±0.20ab
Ectopic foci
-
4.02±0.63c
1.17±0.19ac
1.62±0.28a
2.08±0.20a
Notes: the sham group was administered deionized water. The model group was treated with estradiol valerate combined with oxytocin.
The BD high dose group, BD low dose group, and gestrinone group were intragastrically administered the BD high dose decoction, BD
low dose decoction, and gestrinone solution, respectively. BD: Bushenwenyang decoction. Comparison with the model group, aP < 0.01;
comparison with the sham group, bP < 0.01; comparison with the gestrinone group, cP < 0.01, dP < 0.05.
Table 5 Comparison of nerve growth factor and bradykinin B1 receptor mRNAs ( xˉ ± s)
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In the present study, BD had a similar effect to gestri-
none, and the dose-dependent efficacy of BD on im-
proving the state of dysmenorrhea or decreasing NGF
and BK/BKB1R level was not observed.
In conclusion, we found that BD had beneficial effects
in shrinking the volume of ectopic foci, lengthening
the writhing latency and reducing writhing frequency,
indicating that the decoction from TCM has a protec-
tive effect on dysmenorrhea with endometriosis. The
mechanisms may be associated with the reduction in
the level of serum NGF and BK, and by the reduction
of protein and mRNA levels of NGF and BKB1R.
However, due to the limitation of small sample size
and short study duration, the underlying mechanisms
need further investigation, which might provide more
scientific validation for the clinical application of BD.
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Figure 3 Expressions of NGF and BKB1R byWestern blot
1: sham group; 2 and 6: model group; 3 and 7: BD (Bushenwenyanghuayu decoction) high dose group; 4 and 8: BD low dose
group; 5 and 9: gestrinone group. the sham group was administered deionized water. The model group was treated with estradiol
valerate combined with oxytocin. The BD high dose group, BD low dose group, and gestrinone group were intragastrically admin-
istered the BD high dose decoction, BD low dose decoction, and gestrinone solution, respectively. NGF: nerve growth factor;
BKB1R: bradykinin B1 receptor.
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